封面
市場調查報告書
商品編碼
2050933

融合切片檢查市場:按切片檢查途徑、產品、應用、最終用戶和地區分類

Fusion Biopsy Market, By Biopsy Route, By Product, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 157 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

融合切片檢查市場預計在 2026 年達到 8.615 億美元,預計到 2033 年將達到 15.648 億美元。預計從 2026 年到 2033 年,其複合年成長率將達到 8.9%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 8.615億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 8.90% 2033年市場規模預測: 15.648億美元

融合切片檢查結合了磁振造影(MRI) 和超音波兩種醫學影像技術,提供即時影像引導,從而提高切片檢查手術的準確性。這使得醫生能夠識別體內可疑組織,並以最小的取樣誤差或漏診風險採集組織樣本。前列腺癌、肺癌和乳癌在全球發病率的不斷上升,推動了全球對融合切片檢查切片檢查的需求成長。人口老化、早期癌症診斷意識的提高、醫學影像系統的技術進步以及開發中國家醫療保健成本的上升等因素,預計將在預測期內推動市場成長。

市場動態

全球融合切片檢查市場的發展動力主要來自癌症發病率的上升、微創手術需求的日益成長以及對精準組織取樣技術需求的不斷增加。根據世界衛生組織預測,未來20年全球整體癌症負擔將增加70%以上。融合切片檢查有助於早期發現癌症,同時最大限度地減少取樣誤差,這推動了其在全球的普及。然而,融合切片檢查設備高昂的初始成本和維修成本限制了市場成長。市場參與企業的機會在於拓展新興市場的區域佈局、推出價格親民的設備以及提供計量收費的經營模式。未來幾年,隨著整合人工智慧、機器人和3D成像技術的先進設備獲得核准並上市,也將創造新的機會。例如,2022年,醫療設備醫療設備CMR Surgical憑藉其Versius機器人軟組織手術系統獲得了美國FDA的突破性醫療器材認定。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數對全球融合切片檢查市場的主要參與者進行了分析:公司亮點、產品系列、主要特徵、財務表現和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球融合切片檢查市場報告旨在為行業內的各種相關人員提供參考,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過用於分析全球融合切片檢查市場的各種策略矩陣,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
    • 影響分析
    • 主要進展
    • 監管趨勢
    • 產品上市及核准
    • PEST分析
    • 波特的分析
    • 併購情景
    • 產業趨勢

第4章 全球融合切片檢查市場:依切片檢查途徑分類,2021-2033年

  • 經直腸
  • 經會陰

第5章 全球融合切片檢查市場:依產品分類,2021-2033年

  • 裝置
  • 消耗品

第6章 全球融合切片檢查市場:依應用領域分類,2021-2033年

  • 攝護腺癌
  • 其他

第7章 全球融合切片檢查市場:依最終用戶分類,2021-2033年

  • 醫院
  • 診斷中心
  • 門診部
  • 學術和研究機構
  • 其他

第8章 全球融合切片檢查市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第9章 競爭情勢

  • GE Healthcare
  • Koninklijke Philips NV
  • FUJIFILM Corporation
  • Siemens Healthineers
  • Hitachi, Ltd.
  • Canon Medical Systems Corporation
  • Medtronic
  • Hologic, Inc.
  • Varian Medical Systems
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Agilent Technologies, Inc.
  • 3M Company
  • Carestream Health
  • Neusoft Medical Systems Co., Ltd.

第10章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI7697

Fusion Biopsy Market is estimated to be valued at USD 861.5 Mn in 2026 and is expected to reach USD 1,564.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 861.5 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 8.90% 2033 Value Projection: USD 1,564.8 Mn

Fusion biopsy combines two medical imaging technologies, magnetic resonance imaging (MRI), and ultrasound, to provide real-time image guidance for biopsy procedures with improved accuracy. It helps physicians locate suspicious tissue in the body and obtain tissue samples with minimal risk of sampling error or missing lesions. With rising cases of prostate, lung, and breast cancer worldwide, the demand for advanced biopsy techniques like fusion biopsy is increasing globally. Factors such as growing geriatric population, increasing awareness about early cancer diagnosis, technological advancements in medical imaging systems, and rising healthcare expenditure in developing countries are expected to drive the market growth during the forecast period.

Market Dynamics

The global fusion biopsy market is driven by the rising prevalence of cancer, increasing preference for minimally invasive surgeries, and growing need for accurate tissue sampling techniques. According to WHO, cancer burden is expected to rise by over 70% in the next 20 years worldwide. Fusion biopsy aids in detecting cancers at an early stage with minimal chances of sampling errors. This is propelling its adoption globally. However, high installation and maintenance costs of fusion biopsy devices is restraining market growth. Opportunities for market players lie in expanding their regional presence in emerging markets, launching affordable devices and offering pay-per-use business models. Increasing approvals and launch of advanced devices integrated with artificial intelligence, robotics and 3D imaging technologies will also offer new opportunities in coming years. For example, in 2022, CMR Surgical, a medical equipment manufacturer, received breakthrough device designation from the U.S. FDA for its Versius surgical robotic system for soft tissue procedures.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global fusion biopsy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include GE Healthcare, Koninklijke Philips N.V., FUJIFILM Corporation, Siemens Healthineers, Hitachi, Ltd., Canon Medical Systems Corporation, Medtronic, Hologic, Inc., Varian Medical Systems, Boston Scientific Corporation, Becton, Dickinson and Company, Agilent Technologies, Inc., 3M Company, Carestream Health, and Neusoft Medical Systems Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global fusion biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fusion biopsy market.

Market Segmentation

  • Biopsy Route Insights (Revenue, USD Mn, 2021 - 2033)
  • Transrectal
  • Transperineal
  • Product Insights (Revenue, USD Mn, 2021 - 2033)
  • Equipment
    • MRI machines
    • Ultrasound devices
    • Fusion biopsy systems
    • Others
  • Consumables
    • Biopsy needles
    • Imaging contrast agents
    • Others
  • Application Insights (Revenue, USD Mn, 2021 - 2033)
  • Prostate Cancer
  • Others
  • End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Care Centers
  • Academic & Research Laboratories
  • Others
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • GE Healthcare
  • Koninklijke Philips N.V.
  • FUJIFILM Corporation
  • Siemens Healthineers
  • Hitachi, Ltd.
  • Canon Medical Systems Corporation
  • Medtronic
  • Hologic, Inc.
  • Varian Medical Systems
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Agilent Technologies, Inc.
  • 3M Company
  • Carestream Health
  • Neusoft Medical Systems Co., Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Fusion Biopsy Market, By Biopsy Route
    • Global Fusion Biopsy Market, By Product
    • Global Fusion Biopsy Market, By Application
    • Global Fusion Biopsy Market, By End User
    • Global Fusion Biopsy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER's Analysis
    • Merger and Acquisition Scenario
    • Industry Trends

4. Global Fusion Biopsy Market, By Biopsy Route, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Transrectal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Transperineal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

5. Global Fusion Biopsy Market, By Product, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
      • MRI machines
      • Ultrasound devices
      • Fusion biopsy systems
      • Others
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
      • Biopsy needles
      • Imaging contrast agents
      • Others

6. Global Fusion Biopsy Market, By Application, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

7. Global Fusion Biopsy Market, By End User, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Ambulatory Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Academic & Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

8. Global Fusion Biopsy Market, By Region, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Koninklijke Philips N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • FUJIFILM Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hitachi, Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Canon Medical Systems Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hologic, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Varian Medical Systems
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • 3M Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Carestream Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neusoft Medical Systems Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us